Skip to main content
. 2009 Sep 29;101(2):440–447. doi: 10.1111/j.1349-7006.2009.01375.x

Figure 3.

Figure 3

 Cell cycle effects at IC50 concentrations of trifluorothymidine (TFT) (T), erlotinib (E), simultaneous combination (T + E), and the sequential combinations where cells were preincubated for 24 h with TFT (T → T + E) or E (E → T + E) followed by the T + E combination in WiDR, Lovo92 and Colo320 colorectal cancer cells. Values represent means of at least four independent experiments ± SEM. *Significant differences between treated and control (C) (P < 0.05).